This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gadelha, M. R. Articles by Frohman, L. A. Search for Related Content PubMed PubMed Citation Articles by Gadelha, M. R. Articles by Frohman, L. A.

Isolated Familial Somatotropinomas: Establishment of Linkage to Chromosome 11q13.1–11q13.3 and Evidence for a Potential Second Locus at Chromosome 2p16–12¹

Department of Medicine, University of Illinois at Chicago (M.R.G., R.D.K., L.A.F.), Chicago, Illinois 60612; the Division of Endocrinology, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro (M.R.G., K.N.U., M.V.), Rio de Janeiro, Brazil 21949-590; and the Department of Bioinformatics, Max Delbrück Center for Molecular Medicine (K.R.), Berlin, Germany

Address all correspondence and requests for reprints to: Lawrence A. Frohman, M.D., Department of Medicine (M/C 787), University of Illinois at Chicago, 840 South Wood, Chicago, Illinois 60612.

The majority of somatotropinomas are sporadic, although a small number occur with a familial aggregation, either as a component of an endocrine neoplasia complex that includes multiple endocrine neoplasia type 1 (MEN-1) and Carney complex (CNC) or as isolated familial somatotropinomas (IFS). IFS is defined as the occurrence of at least two cases of acromegaly or gigantism in a family that does not exhibit MEN-1 or CNC. This rare disease is associated with loss of heterozygosity (LOH) on chromosome 11q13, the locus of the MEN-1 gene, although the MEN-1 sequence and expression appear normal. These data suggest the presence of another tumor suppressor gene located at 11q13 that is important in the control of somatotrope proliferation. To establish linkage of IFS to 11q13 and to define the candidate interval of the IFS gene, we performed haplotype and allelotype analyses on two families with IFS. Collectively, allelic retention in one tumor and a recombinant haplotype in an affected individual mapped the tumor suppressor gene involved in the pathogenesis of IFS to a region of 8.6 cM between polymorphic microsatellite markers D11S1335 and INT-2 located at chromosome 11q13.1–13.3. Maximum two-point LOD scores for five markers within this region were 3.0 or more at = 0.0. As somatotropinomas are the predominant pituitary tumor subtype associated with CNC and arise before 30 yr of age, which is strikingly similar to the age at diagnosis for IFS, we explored the possibility that the putative CNC genes might also contribute to the pathogenesis of IFS. Although the genetic defect responsible for the complex is unknown, CNC has been mapped by linkage analysis to chromosomes 2p15–16 and 17q23–24 in different kindreds. Two-point LOD scores less than -2.0 were obtained using marker D17S949 from chromosome 17q23–24, excluding linkage. However, LOD scores of 2.5 were obtained for markers within 2p16–12; therefore, linkage of IFS to chromosome 2p cannot be excluded. This report establishes linkage of the tumor suppressor gene involved in the pathogenesis of IFS to chromosome 11q13.1–13.3 and identifies a potential second locus at chromosome 2p16–12.

This article has been cited by other articles:

				S K Khoo, R Pendek, R Nickolov, D C Luccio-Camelo, T L Newton, A Massie, D Petillo, J Menon, D Cameron, B T Teh, et al. Genome-wide scan identifies novel modifier loci of acromegalic phenotypes for isolated familial somatotropinoma Endocr. Relat. Cancer, September 1, 2009; 16(3): 1057 - 1063. [Abstract] [Full Text] [PDF]

				C. A. Leontiou, M. Gueorguiev, J. van der Spuy, R. Quinton, F. Lolli, S. Hassan, H. S. Chahal, S. C. Igreja, S. Jordan, J. Rowe, et al. The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2390 - 2401. [Abstract] [Full Text] [PDF]

				S. Melmed Update in Pituitary Disease J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 331 - 338. [Abstract] [Full Text] [PDF]

				S. Melmed Aryl Hydrocarbon Receptor Interacting Protein and Pituitary Tumorigenesis: Another Interesting Protein J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1617 - 1619. [Full Text] [PDF]

				A. F. Daly, J.-F. Vanbellinghen, S. K. Khoo, M.-L. Jaffrain-Rea, L. A. Naves, M. A. Guitelman, A. Murat, P. Emy, A.-P. Gimenez-Roqueplo, G. Tamburrano, et al. Aryl Hydrocarbon Receptor-Interacting Protein Gene Mutations in Familial Isolated Pituitary Adenomas: Analysis in 73 Families J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1891 - 1896. [Abstract] [Full Text] [PDF]

				R. A. Toledo, D. M. Lourenco Jr., B. Liberman, M. B. C. Cunha-Neto, M. G. Cavalcanti, C. B. Moyses, S. P. A. Toledo, and P. L. M. Dahia Germline Mutation in the Aryl Hydrocarbon Receptor Interacting Protein Gene in Familial Somatotropinoma J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1934 - 1937. [Abstract] [Full Text] [PDF]

				O. Vierimaa, M. Georgitsi, R. Lehtonen, P. Vahteristo, A. Kokko, A. Raitila, K. Tuppurainen, T. M. L. Ebeling, P. I. Salmela, R. Paschke, et al. Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene. Science, May 26, 2006; 312(5777): 1228 - 1230. [Abstract] [Full Text] [PDF]

				B. S. Soares, K. Eguchi, and L. A. Frohman Tumor Deletion Mapping on Chromosome 11q13 in Eight Families with Isolated Familial Somatotropinoma and in 15 Sporadic Somatotropinomas J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6580 - 6587. [Abstract] [Full Text] [PDF]

				B. Asgharian, Y.-J. Chen, N. J. Patronas, P. L. Peghini, J. C. Reynolds, A. Vortmeyer, Z. Zhuang, D. J. Venzon, F. Gibril, and R. T. Jensen Meningiomas May Be a Component Tumor of Multiple Endocrine Neoplasia Type 1 Clin. Cancer Res., February 1, 2004; 10(3): 869 - 880. [Abstract] [Full Text] [PDF]

				F. Gibril, Y.-J. Chen, D. S. Schrump, A. Vortmeyer, Z. Zhuang, I. A. Lubensky, J. C. Reynolds, A. Louie, L. K. Entsuah, K. Huang, et al. Prospective Study of Thymic Carcinoids in Patients with Multiple Endocrine Neoplasia Type 1 J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1066 - 1081. [Abstract] [Full Text] [PDF]

				F Sandrini, L S Kirschner, T Bei, C Farmakidis, J Yasufuku-Takano, K Takano, T R Prezant, S J Marx, W E Farrell, R N Clayton, et al. PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex J. Med. Genet., December 1, 2002; 39(12): e78 - 78. [Full Text] [PDF]

				M. L. Brandi, R. F. Gagel, A. Angeli, J. P. Bilezikian, P. Beck-Peccoz, C. Bordi, B. Conte-Devolx, A. Falchetti, R. G. Gheri, A. Libroia, et al. CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2 J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5658 - 5671. [Abstract] [Full Text] [PDF]

				B. H. Jorge, S. K. Agarwal, V. S. Lando, R. Salvatori, R. R. Barbero, N. Abelin, M. A. Levine, S. J. Marx, and S. P. A. Toledo Study of the Multiple Endocrine Neoplasia Type 1, Growth Hormone-Releasing Hormone Receptor, Gs{{alpha}}, and Gi2{{alpha}} Genes in Isolated Familial Acromegaly J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 542 - 544. [Abstract] [Full Text]

				C. A. Stratakis and L. S. Kirschner Isolated Familial Somatotropinomas: Does the Disease Map to 11q13 or to 2p16? J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4920 - 4924. [Full Text]

				M. R. Gadelha, K. Rhode, R. D. Kineman, and L. A. Frohman Authors' Response: Isolated Familial Somatotropinomas: Does the Disease Map to 11q13 or to 2p16? J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4921 - 4921. [Full Text]